Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T73579 |
YM-1
|
||
YM-1 是稳定的和可溶性的MKT-077 类似物和具有口服活性的Hsp70抑制剂。YM-1 诱导 HeLa 细胞死亡,上调p53和p21的蛋白水平。 | |||
T35261 |
YM 26567-1
YM-26567-1,YM26567-1 |
||
YM 26567-1 is a biochemical. | |||
T35256 |
YM 16151-1
YM-16151,YM16151 |
||
YM 16151-1 is a biochemical. | |||
T8436 |
Minodronic acid
Phosphonicacid,(1-hydroxy-2-imidazo(1,2-a)pyridin-3-ylethylidene)bis-,ONO-5920,YM-529 |
Apoptosis; P2X Receptor | Apoptosis; Membrane transporter/Ion channel; Neuroscience |
Minodronic acid(YM-529) 是一种 P2X2/3 受体拮抗剂, 具有抗癌活性,可直接或间接的抑制癌细胞增殖,诱导细胞凋亡。Minodronic-acid 对各种类型的癌细胞的转移具有抑制作用。Minodronic-acid 可用于研究骨质疏松。 | |||
T7417 |
Avatrombopag
YM477,AKR-501,1-[3-氯-5-[[[4-(4-氯-2-噻吩基)-5-(4-环己基-1-哌嗪基)-2-噻唑基]氨基]羰基]-2-吡啶基]-4-哌啶羧酸,E5501 |
Thrombin; Thrombopoietin Receptor | Immunology/Inflammation; Proteases/Proteasome |
Avatrombopag (YM477) 是一种新型口服血小板生成素 (TPO) 受体激动剂,可激活 TPO 受体并增加巨核细胞增殖/分化和血小板生成。 | |||
T7550 |
Barnidipine
YM-09730-5(Free base),(4S)-2,6-二甲基-4-(间硝基苯基)-1,4-二氢吡啶-3,5-二羧酸 (3S)-1-苄基-3-吡咯烷基-甲基酯,Mepirodipine |
Calcium Channel | Membrane transporter/Ion channel; Metabolism |
Barnidipine (YM-09730-5(Free base)) 是一种二氢吡啶类钙通道阻滞剂,对 CaA 受体具有选择性作用。它是一种抗高血压药物,通过减少其血管扩张作用继发的外周血管阻力起作用。 | |||
T29183 |
YM-430
YM-15430,YM-15430-1,YM-154301,YM-15430-2,YM430,YM-15430-3 |
||
YM-430 is a β1 adrenergic receptor antagonist and a calcium channel antagonist. YM430 could be both an antianginal and antihypertensive agent. YM430 (10(-8)-10(-6) M) inhibited 3,4-diaminopyridine-induced rhythmic contractions with an IC50 value of 59.2 n | |||
T8435 |
YM90K
YM90K hydrochloride,6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-,1,4-二氢-6-(1H-咪唑-1-基)-7-硝基-2,3-喹喔啉二酮单盐酸盐 |
GluR; iGluR | Membrane transporter/Ion channel; Neuroscience |
YM90K (6-(1H-imidazol-1-yl)-7-nitro-2,3(1H,4H)-) hydrochloride 是一种选择性的、有效的AMPA 受体拮抗剂,Ki=84 nM。YM90K 抑制海藻酸酯 (Ki 为 2.2 μM) 和 NMDA (Ki 为 37 μM) 受体的效力较低,并具有神经保护活性。 | |||
T19629 |
Indeloxazine hydrochloride
CI-874l,Indeloxazine HCl,YM 08054-1,Indeloxazine,CI 874,CI874l |
||
Indeloxazine HCl acts as a serotonin releasing agent, norepinephrine reuptake inhibitor, and NMDA receptor antagonist. Indeloxazine hydrochloride is an antidepressant and cerebral activator. It has been found to enhance acetylcholine release in the rat fo | |||
T29182 |
YM-358 potassium hydrate
YM-358,YM358,YM 358 |
||
YM-358 potassium hydrate is an orally active and long-lasting antagonist of angiotensin type 1 receptor. | |||
T69489 |
YM-202074
|
||
YM-202074 is a high affinity, selective metabotropic glutamate receptor type 1 (mGlu1) antagonist. YM-202074 binds an allosteric site of the rat mGlu1 receptor with a Ki of 4.8 nM. It inhibits mGlu1-mediated inositol phosphates production (IC50 = 8.6 nM in rat cerebellar granule cells). | |||
T76979 | Tadocizumab | ||
Tadocizumab(C4G1; YM-337)是针对整合素αIIbβ3的人源化单克隆抗体。它展现出抗血小板与抗血栓功能,适用于心血管疾病的研究。 | |||
T21834 |
YM-155 hydrochloride
|
||
Sepantronium hydrochloride (YM-155 hydrochloride) 是一种新型survivin 抑制剂,抑制survivin 启动子的IC50为 0.54 nM。 | |||
T80752 |
YM-08
|
Sirtuin | Chromatin/Epigenetic; DNA Damage/DNA Repair |
YM-08(Compounds 7a),一种能穿透血脑屏障的SIRT2抑制剂,具有19.9 μM的IC50值,同时也抑制Hsp70。 |